Analysis of the cystic fibrosis lung microbiota via serial Illumina sequencing of bacterial 16S rRNA hypervariable regions

PLoS One. 2012;7(10):e45791. doi: 10.1371/journal.pone.0045791. Epub 2012 Oct 2.

Abstract

The characterization of bacterial communities using DNA sequencing has revolutionized our ability to study microbes in nature and discover the ways in which microbial communities affect ecosystem functioning and human health. Here we describe Serial Illumina Sequencing (SI-Seq): a method for deep sequencing of the bacterial 16S rRNA gene using next-generation sequencing technology. SI-Seq serially sequences portions of the V5, V6 and V7 hypervariable regions from barcoded 16S rRNA amplicons using an Illumina short-read genome analyzer. SI-Seq obtains taxonomic resolution similar to 454 pyrosequencing for a fraction of the cost, and can produce hundreds of thousands of reads per sample even with very high multiplexing. We validated SI-Seq using single species and mock community controls, and via a comparison to cystic fibrosis lung microbiota sequenced using 454 FLX Titanium. Our control runs show that SI-Seq has a dynamic range of at least five orders of magnitude, can classify >96% of sequences to the genus level, and performs just as well as 454 and paired-end Illumina methods in estimation of standard microbial ecology diversity measurements. We illustrate the utility of SI-Seq in a pilot sample of central airway secretion samples from cystic fibrosis patients.

MeSH terms

  • Bacteria / classification
  • Bacteria / genetics*
  • Computer Simulation
  • Cystic Fibrosis / microbiology*
  • DNA, Bacterial / chemistry
  • DNA, Bacterial / genetics
  • Genetic Variation
  • Humans
  • Lung / microbiology
  • Lung / pathology
  • Metagenome / genetics*
  • Phylogeny
  • Polymerase Chain Reaction
  • RNA, Ribosomal, 16S / genetics*
  • Sequence Analysis, DNA / methods*
  • Sputum / microbiology

Substances

  • DNA, Bacterial
  • RNA, Ribosomal, 16S

Grants and funding

This work was supported by: the Canadian Institutes of Health Research, Human Microbiome Emerging Team Grant (CMF108027) (http://www.cihr-irsc.gc.ca/e/193.html); the National Sanitarium Association (http://nationalsanitarium.ca/); and Cystic Fibrosis Canada (www.cysticfibrosis.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.